Corrigendum to Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: An Australian perspective [American Journal of Preventive Cardiology 6 (2021) 100151]
Gerald F. Watts(Royal Perth Hospital), Jing Pang(The University of Western Australia), David L. Hare(The University of Melbourne), Nicola Poplawski(Royal Adelaide Hospital), Karam Kostner(Mater Health Services), Ari Horton(Monash Children’s Hospital), Andrew C. Martin(Princess Margaret Hospital for Children), David Sullivan(Royal Prince Alfred Hospital), Tom Brett(The University of Notre Dame Australia), Robert Justo, Ronald J. Trent(John Radcliffe Hospital), Damon A. Bell(South Australia Pathology), Shubha Srinivasan(Children's Hospital at Westmead), Clara K Chow(Westmead Hospital)
Cited by 0
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k